|
|
DSpace at RU >
Browsing by Author Wijermans, P.W.
Showing results 1 to 12 of 12
| Full Text | Issue Date | Title | Author(s) | | 2011 | Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40 | Rijneveld, A.W.; Holt, B. van der; Daenen, S.M.G.J.; Biemond, B.J.; Weerdt, O. de, et al |
| 2011 | Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group | Lubbert, M.; Suciu, S.; Baila, L.; Ruter, B.H.; Platzbecker, U., et al |
| 2010 | Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia. | Deenik, W.; Janssen, J.J.M.; Holt, B. van der; Verhoef, G.E.; Smit, W.M., et al |
| 2008 | Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia. | Deenik, W.; Holt, B. van der; Verhoef, G.E.; Smit, W.M.; Kersten, M.J., et al |
| 2007 | Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma : long-term follow-up of the Dutch Cooperative Group HOVON 24 trial | Sonneveld, P.; Holt, B. van der; Segeren, C.M.; Vellenga, E.; Croockewit, A.J., et al |
| 2007 | Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. | Gorkom, B.A.P. van; Huisman, C.A.; Wijermans, P.W.; Schipperus, M.R. |
| 2006 | Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. | Cheson, B.D.; Greenberg, P.L.; Bennett, J.M.; Lowenberg, B.; Wijermans, P.W., et al |
| 2005 | Splenectomy for the treatment of thrombotic thrombocytopenic purpura. | Kappers-Klunne, M.C.; Wijermans, P.W.; Fijnheer, R.; Croockewit, A.J.; Holt, B. van der, et al |
| 2005 | Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. | Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Ossenkoppele, G.J.; Wijermans, P.W., et al |
| 2005 | Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40. | Imhoff, G.W. van; Holt, B. van der; MacKenzie, M.A.; Veer, M.B. van 't; Wijermans, P.W., et al |
| 1997 | Trombotische trombocytopenische purpura in 13 Nederlandse centra: behandeling en beloop | Kappers-Klunne, M.C.; Meulen, J.H.P. van der; Holdrinet, R.S.G.; Meer, J. van der; Wijermans, P.W., et al |
| 1995 | Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? | Heijer, M. den; Blom, H.J.; Gerrits, W.B.J.; Rosendaal, F.R.; Haak, H.L., et al |
Showing results 1 to 12 of 12
|